Synergizing with Phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor, PLG-CA4 diminishes tumor metastasis in metastatic breast cancer by increasing the polarization of tumor-associated macrophages (TAMs) toward the M2-like phenotype (75). This evidence concerns the gene PLG and neoplasm.